In a more recent publication, the same authors report the modification of the described agarose/HA-composite by adding vascular endothelial growth factor (VEGF) and mesoporous silica nanoparticles loaded with the antibiotic cephalexin to improve vascularization and reduce infections during bone defect healing. The gene discussed is VEGFA; the disease is infection.